108results about How to "Easy treatment" patented technology

A disposable therapeutic device for the promotion of wound healing providing fluid irrigation and vacuum drainage of a wound includes a housing containing a controller and fluid moving device in a waterproof manner, a fluid mover capable of raising, compressing, or transferring fluid, a controller equipped to restrict fluid moving device in accordance with a predetermined treatment plan or duration, a chargeable power source removably connected to the housing, an optional therapeutic member of a compressible dressing or inflatable cuff to provide hemostasis, an identification member for regulating the operation of the device in accordance with a predetermined treatment plan, a disposable container, a pressure sensor and a control display panel. The fluid includes, but is not limited to, Lactoferrin, Xylitol, Dakins Solution, Polyhexanide and Hypochlorous Acid.

Methods and compositions are provided for the treatment of articular cartilage defects and disease involving the combination of tissue, such as osteochondral grafts, with active growth factor. The active growth factor is preferably a composition containing at least one bone morphogenetic protein and a suitable carrier. The method results in the regeneration and / or functional repair of articular cartilage tissue.

Embodiments of the present invention relate to enhanced antiviral therapy methods, devices, and kits for treating viral infections. The disclosed enhanced antiviral therapy methods, devices, and kits enhance the efficacy of an antiviral therapy by administering a lectin affinity hemodialysis treatment to an individual suffering from viral infection in combination with the antiviral therapy.

The invention discloses a magnetic needle diagnosis and treatment system which comprises a main control module, a magnetic needle probe module, a physiological parameter collecting module and a data processing module. By testing physiological parameters in pretherapy and post-treatment and comparing and diagnosing the physiological parameters in pretherapy and post-treatment, treatment effect of the magnetic needle diagnosis and treatment system can be displayed visually. By combining diagnosis and treatment, judging the treatment effect by intuitive feelings of the patient is avoided so as to prevent judging of the treatment effect and improving of treatment method from being affected, using of external test instruments is avoided, tests are simple and convenient to carry out, cost is lowered, uniqueness and pertinence of test data are guaranteed, portability and comfort of instruments are satisfied, and the instruments are capable of entering communities easily and close to an idea of low cost and healthy life of the whole people.

A pharmaceutical composition containing one or more antifungal agents selected from an arylamidine derivative represented by the general formula:(wherein R1 represents an amidino group that may be substituted with a hydroxyl group that may be protected with an acyl group, an amidino group that may be substituted with an alkoxy group that may be substituted, or an amidino group that may be substituted with an aralkyloxy group that may be substituted; R2 and R3 identically or differently represent a hydrogen atom or a halogen atom) or a salt thereof, an azole antifungal agent, a polyene antifungal agent, a candin antifungal agent and a fluoropyrimidine antifungal agent has a strong antifungal activity and is useful for the treatment of fungal infection. A method for using them in combination is useful as an excellent therapeutic method for fungal infection. A pharmaceutical composition containing the arylamidine derivative represented by the above general formula or a salt thereof and an immunosuppressant has a strong antifungal activity and is useful for the treatment of fungal infection and a skin disease such as atopic dermatitis. A method for using them in combination is useful as an excellent therapeutic method for fungal infection and a skin disease such as atopic dermatitis.

Methods and compositions are provided for the treatment of articular cartilage defects and disease involving the combination of tissue, such as osteochondral grafts, with active growth factor. The active growth factor is preferably a composition containing at least one bone morphogenetic protein and a suitable carrier. The method results in the regeneration of functional repair of articular cartilage tissue.

The invention provides an active radio capsule endoscope probe for a digestive tract, which comprises a probe holding part, a magnetism generating module and a magnetism generating control circuit, wherein the magnetism generating module and the magnetism generating control circuit are arranged in the probe holding part; at least one magnetic field intensity operating key is arranged outside the probe holding part; when a capsule endoscope picks up an image in the digestive tract, the magnetism generating control circuit generates an excitation signal to the magnetism generating module so that the magnetism generating module forms a preset magnetic field type in the distributing front end of the magnetic field of the probe holding part due to electromagnetic induction; and the magnetic field intensity operating key is used for modulating the magnetic field intensity of the preset magnetic field type of the magnetism generating module so as to control the magnetic clamping force between the capsule endoscope and the probe.

The invention provides a Chinese medicament for treating prostate diseases, which comprises tomato powder 30-70%, sunflower seed 30-70%, wherein the formulation contains rich Vitamin E and organic selenium.

The invention provides a characteristic protein fragment composition for detecting thalassemia and a mass spectrometry model for evaluating therapeutic effect of thalassemia medicine or evaluating effect of a treatment method, wherein the sequence of the characteristic protein fragment composition is shown in SEQ ID No.1-3, respectively. The characteristic protein fragment composition or mass spectrometry model provided by the invention can be used for the diagnosis and screening of thalassemia, as well as the evaluation of the treatment method and drug efficacy of thalassemia. The method is simple and easy to operate, and high in accuracy, and provides new methods and ideas for the evaluation of diagnosis and screening, treatment methods and drug efficacy of thalassemia.

The invention provides a mass spectrum model for detecting characteristic protein fragment compositions of thalassemia and evaluating the medicinal curative effect of the thalassemia or the effect ofa treatment method. The sequences of the characteristic protein fragment compositions are shown in SEQ ID No. 1-3 respectively. The characteristic protein fragment compositions or the mass spectrum model can be used for diagnosis and screening of the thalassemia as well as evaluation of the treatment method and the medicinal curative effect of the thalassemia; and the method is simple, easy to operate and high in accuracy, and a new method and thought are provided for the diagnosis and screening, the treatment method and the medicinal curative effect of the thalassemia.

Compositions and methods for treatment of individuals diagnosed with a dystrophin deficiency are disclosed. In particular, inhibitors of NFκB activation, such as pyrrolidine dithiocarbamate (PDTC), have been shown to prevent and reverse muscle damage in animals lacking dystrophin. Such compositions and methods are useful in the treatment of individuals with muscular dystrophy.

A method for configuring the eucaryotic expression carrier of cell factor IL-24 includes designing the ascending and descending primers, PCR amplifying begining from the second amino acid in the code at human IL-24 N terminal by using TRAPIL-24 plasmid as template, cutting off target band, purifying it with reagent kit, configuring and determining recombinant plasmid pEGFP-CI-IL-24, respectively enzyme-severing the PCR product and carrier pEGFP by Bgl II and Sal I, purifying them by reagent kit, linking fragment, culturing, cloning, determining and sequencing. The recombinant cell factor Il-24 can be used to treat liver cancer, small intestine cancer and melanoma.

A test bench for testing a brake comprises a pressure generating assembly for providing a brake fluid with an increased hydraulic pressure, a test bench control, and an electromechanical brake actuator. The pressure generating assembly is actuated mechanically and the brake fluid is supplied to the brake to actuate the brake. The electromechanical brake actuator, which simulates a vehicle driver's braking foot, is provided for mechanical actuation of the pressure generating assembly. The brake actuator comprises an electric motor activated by the test bench control and a planetary roller screw drive driven by the electric motor. The planetary roller screw drive is mechanically coupled to the pressure generating assembly to mechanically actuate the pressure generating assembly.

The invention relates to the fields of bioengineering and biomedicine, in particular to a 3D printing material, a neural restoration catheter and a preparation method of the neural restoration catheter. The novel 3D printing material is provided by the invention, substances capable of reducing ultraviolet light transmittance are added into conventional raw materials for biomaterial printing, and thus the 3D printing material can be used for high-precision printing is obtained. Through the material, high-precision biomaterials such as the neural restoration catheter can be prepared by 3D printing equipment.

The invention discloses a formula of an incised wound ointment, and a preparation method of the incised wound ointment, and relates to the field wound treatment medicines. The formula of the incised wound ointment comprises 5-10g of Cordyceps sinensis, 5-10g of wild Mythic Fungus, 5-10g of musk, 5-10g of dragon's blood, 2-5g of Herbal Ephedrae, 2-5g of Boswellia carteri, 5-10g of catechu, 5-10g of myrrh, 1-3g of ground beetle, 6-15g of Chinese angelica, 5-10g of Fructus Cnidii, 5-10g of processed Nux Vomica, 5-10g of Radix Aconiti Kusnezoffii Preparata and 5-10g of scorpion. The preparation method of the incised wound ointment comprises the following steps: crushing above traditional Chinese medicines by a crusher or milling with a stone to form powder, carrying out coarse mesh filtration, carrying out fine mesh filtration, crushing to form powder, and boiling in a copper pot by using a copper soon with slow fire to prepare an ointment. The incised wound ointment is suitable for of blood wounds, bullet wounds, cut wounds, operation wound non-healing, diabetic feet, bedsores, burns, scalds, contusions and the like, is in favor of dredging channels and collaterals, reconstructing cells, regenerating fertile soil and multiplying the human body regeneration capability.

The use of benzazepin-N-acetic acid derivatives which contain an oxo group in the a position to the nitrogen atom and are substituted in the 3 position by a 1-(carboxyalkyl)-cyclopentyl-carbonyl-amino radical, and of their salts and biolabile esters, for the prophylaxis and / or treatment of heart damage caused by cardiotoxic doses of medicaments or chemicals, in larger mammals and in particular humans. The invention is particularly applicable to the prophylaxis and / or treatment of heart damage, in particular to the myocardium, which may occur during cytostatic chemotherapy. The invention also includes the use of the afore-mentioned benzazepin-N-acetic acid derivatives for adjuvant treatment in therapies in which medicaments having oxidative-toxic side-effects are used, and the preparation of medicaments suitable for this prophylaxis and / or treatment or adjuvant treatment.

The present invention relates to a medicine composition for preventing and curing diabetes type I and its application. Said medicine composition includes (1), polypeptide capable of curing diabetes type I and (2), nucleic acid vaccine possesses the polypeptide which has 50% of homology respectively with proinsulin, GAD65 and B7-1 wa polypeptide which can be combined with T cell negative regulator CTLA-4. The invented medicine composition can effectively prevent and cure diabetes type I.

The invention provides a Chinese herbal preparation for curing pneumoconiosis and tuberculosis, prepared of Radix Achyranthis Bidentatae 10-20g, Epimedium Herb 12-20g, Bitter Bamboo Leaf 10-24g, Chinese Thorowax Root 10-20g, and honey 20-30g by soaking in white spirit 400-500 ml for 15-20 days, filtering out dregs, and sterilizing. And it has characters of simple preparing process, convenient to use and good curative effect.

The invention relates to a traditional Chinese medicine pill and in particular relates to a traditional Chinese medicine pill for treating gout. According to the traditional Chinese medicine pill, theadopted cortex phellodendri, rhizoma atractylodis, semen coicis and medicinal cyathula root have effects of clearing away heat and drying dampness to remove red and swollen heat pain of downward flowof damp-heat, the medicines reach the lesions, and the four medicines are combined to achieve the effects of clearing and treating both symptoms and root causes and are taken as the monarch drug; salvia miltiorrhiza, radix curcumae, corydalis tuber, red paeony root and caulis spatholobi can achieve effects of promoting blood circulation to remove blood stasis, relieving pain and promoting qi circulation and helping monarch drug to clear away heat, and have monarch drug effect of clearing middle-jiao heat so as to serve as ministerial drug; grifola, rhizoma alismatis, plantain herb and dandelion have effects of clearing heat and promoting diuresis and inducing lower-jiao water-dampness and helping the ministerial drug to well promote blood circulation to remove blood stasis so as to serveas the adjuvant; and dried tangerine or orange peel and lily are taken as conductant drug, achieve effects of clearing middle-jiao dampness to invigorate spleen, and are matched with other traditionalChinese medicines to well achieve effect of clearing damp. The traditional Chinese medicine pill is used for treating gout by utilizing overall synergistic effects of various medicines, is small in side effects to human body, does not need to be decocted, has characteristics of being simple and convenient in treatment method, low in price and obvious in curative effects, and has effects of clearing heat and expelling damp, promoting blood circulation to arrest pain and treating both symptoms and root causes, and efficiency of treating gout reaches 97% or higher.

The present invention relates generally to a method for identifying or distinguishing one type of cell from other cells within a population of cells. The present invention further provides the detection, monitoring and isolation of sub-populations cell types within a population of cells including a biological entity comprising such cell types. Kits, diagnostic agents and panels of nucleic acid probes for identifying and distinguishing cell types also form part of the present invention. The detection of particular cell types is based upon the use of a labelled probe that hybridizes to chromosomal DNA at the flanking sequences of a deletion. Alternatively two probes with distinguishable reporter molecules are used wherein only one probe is capable of hybridizing to chromosomal DNA in one cell type whereas both are capable of hybridizing to chromosomal DNA in another cell type. The methods are useful in the identification of cells with copy number variations, chromosomal deletions, additions or aberrations.

The invention discloses a heptamethyl cyanine dye-crosslinked tetracyclic amine chelating agent conjugate. The conjugate comprises a heptamethyl cyanine dye (HMCD) group coupled by a crosslinking agent group L and a crosslinked tetracyclic amine (CTC) chelating agent residue R; the cross-linking agent group L is composed of zero or one or more amino acid residues; the residue R of the cross-linked tetracyclic amine (CTC) chelating agent is a group consisting of CB-TE2A or DiAmSar or a derivative of the CB-TE2A or DiAmSar; and the residue R of the cross-linked tetracyclic amine (CTC) chelating agent is combined with <64>Cu. According to the scheme, the copper compound containing DZ-1-(L)-CTC can provide improved serum stability compared with copper compounds known in the past, and meanwhile, the tumor targeting property is reserved, and good imaging quality is provided.

A multi-functional fluid dispensing system and method for dispensing fluid which provides an end-user the ability to control the fluid flow dispensed from the container while, in some embodiments, providing illumination of a target area to which the fluids are desired.

The invention provides a mass spectrum model for detecting a characteristic protein fragment composition of thalassemia and evaluating a therapeutic effect of a thalassemia drug or evaluating an effect of a treatment method. A sequence of the characteristic protein fragment composition is shown as SEQ ID No.1-3. The characteristic protein fragment composition or the mass spectrum model can be usedfor diagnosis and screening of the thalassemia and evaluation of the treatment method of the thalassemia and the therapeutic effect of the drug. The method is simple and easy to operate and is high in accuracy, and a new method and idea is provided for diagnosis and screening of the thalassemia, the treatment method and drug therapeutic effect evaluation.

Described herein are methods for treating breast cancer and for providing a prognosis for metastatic-free survival of breast cancer patients. Aspects relate to treating a patient determined to be at high risk for developing or having metastatic breast cancer comprising administering adjuvant or neoadjuvant therapy to the patient determined to be at high risk for developing or having metastatic breast cancer, wherein the patient was determined to be at high risk for developing or having metastatic breast cancer by determining that the expression level of RKIP was reduced and / or the expression level of one or more of HMGA2, CCL5, TN-FR2, GRN, and CCL7 was elevated in a biological sample from the patient compared to a control non-metastatic tissue sample.

The invention relates to a medicine for treating esophagus cancer and a preparation method thereof. The preparation method is characterized by comprising the following steps: classifying musk, borneol, scorpio, ebony, centipede and eupolyphage sinensis, grinding into fine powder, removing impurities, blending, stirring evenly, then blending with honey, producing finished pills and weighing each pill by 5g. When being taken, one pill is taken, put into the mouth and dissolved by holding in the mouth, the pills are taken for 2 times each day and are respectively taken for 1 time in the morning and in evening, three weeks form one treatment course, and the pills are stopped taking for 1 week after one treatment course, and then are continuously dissolved by holding in the mouth for treatment. The formula is formed by adding and reducing matched treatment on the basis of the traditional formula and has little matched traditional Chinese medicines and low side effect; especially, an oral holding tablet has a therapeutic action on the esophagus cancer of the early period and the middle period and has an obvious effect of prolonging the life for a late-period patient.

The invention discloses an intelligent chair for precise control of the standard body position of digitalized patients in the department of stomatology, which relates to the technical field of medical equipment. Intelligent control system, lighting and image acquisition and recording system, easy to connect with various treatment equipment expansion installation interface, the base of the intelligent chair is equipped with universal wheels and large-angle horizontal slewing bearing device, for the treatment of dentists, the installation and construction of the chair position It is convenient to move the chair when designing the consultation room. It provides support for the unified standard body position in clinical treatment and academic communication in the Department of Stomatology, facilitates faster and better promotion and application of advanced treatment methods based on standard body position conditions, and ensures the maximum efficiency of medical activities, ensuring the mutual benefit of both doctors and patients Fundamental interests.

The invention provides a material for generating calcium phytate in situ to seal dentin lumen and application thereof and belongs to the technical field of dental materials. According to the materialprovided by the invention, a reagent A is an acidic solution of the calcium phytate. The reagent B is an alkaline solution of calcium hydroxide, potassium hydroxide, sodium hydroxide and the like. Thereagent A is brushed on the surface of exposed dentin or is put into a root canal; the reagent A enters a dentin tubule, a lateral branch root canal and the like, and also can reach an apical foramenalong the root canal; then the reagent B is brushed; the acidic solution of the calcium phytate in the dentin tubule, the lateral branch root canal or the apical foramen forms calcium phytate sediment along with the raising of the pH (Potential of Hydrogen) value and the dentin tubule, the lateral branch root canal or the apical foramen is blocked by the calcium phytate sediment. Hydrophilic components including ethanol, ethylene glycol and acetone can be added into the reagent A or the reagent B, so that the permeability is improved, and the dentin tubule, the lateral branch root canal and the apical foramen are further sealed. Elements including a silicon-containing compound and the like also can be added into the reagent B and are used for assisting calcium salt deposition in an oral cavity and tissues, furthermore, the dentin tubule, the lateral branch root canal and apical foramen are sealed.